After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
RGNX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Regenxbio Inc is $519.84M. A total of 0.63 million shares were traded on the day, compared to an average of 643.87K shares.
In the most recent transaction, KARABELAS ARGERIS N sold 10,000 shares of RGNX for 10.11 per share on Oct 01 ’24. After the transaction, the Director now owns 11,286 company shares. In a previous transaction on Sep 03 ’24, KARABELAS ARGERIS N sold 10,000 shares at 11.56 per share. RGNX shares that Director owns now total 11,286.
Among the insiders who sold shares, KARABELAS ARGERIS N disposed of 10,100 shares on Aug 01 ’24 at a per-share price of $13.51. This resulted in the Director holding 11,286 shares of RGNX after the transaction. In another insider transaction, Simpson Curran sold 100 shares at $15.00 per share on Aug 01 ’24. Company shares held by the Chief Executive Officer now total 170,037.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, RGNX has a high of $28.80 and a low of $8.53.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. RGNX’s latest balance sheet shows that the firm has $457.44M in Cash & Short Term Investments as of fiscal 2021. There were $86.68M in debt and $130.47M in liabilities at the time. Its Book Value Per Share was $6.09, while its Total Shareholder’s Equity was $764.30M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RGNX is Buy with a score of 4.83.
